Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Viridian Therapeutics, Inc.\DE (VRDN) Gross Margin: 2014-2025

Historic Gross Margin for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Sep 2025 value amounting to 100.00%.

  • Viridian Therapeutics, Inc.\DE's Gross Margin changed negligibly% to 100.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Viridian Therapeutics, Inc.\DE's Gross Margin stood at 100.00%, which was down 0.00% from 100.00% recorded in Q2 2025.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Gross Margin peaked at 100.00% during Q1 2021, and registered a low of 100.00% during Q1 2021.
  • In the last 3 years, Viridian Therapeutics, Inc.\DE's Gross Margin had a median value of 100.00% in 2025 and averaged 100.00%.